Evio

Evio is a pharmacy solutions company that provides real-world evidence (RWE) analytics, medication contracting, and digital tools for high-cost and specialty medications. Its products include Evio Insights (playbooks, population health detail and dashboards), Evio Engage for longitudinal patient tracking and value-based contract administration, and Evio Compass for identifying high-risk patients.

Its customers are health plans, with solutions also offered to pharmaceutical manufacturers. Evio is wholly owned by six independent health plans, including Blue Cross Blue Shield of Massachusetts, Highmark Inc. and Wellmark Blue Cross and Blue Shield, and works with them to pursue direct purchase and value-based contracts with manufacturers. The company was formed in 2020 by five Blue Cross Blue Shield health plans; Wellmark joined in 2025 as its first non-founding investor.

The six owner health plans serve more than 20 million members in total. Evio is a member and board director of Synergie Medication Collective and uses the Aetion Evidence Platform for its RWE studies. Open roles are listed for the United States, primarily in pharma contracting, legal and technology.

Product: Real-world evidence analytics, medication contracting, and digital tools (Evio Insights, Evio Engage, Evio Compass) for health plans and pharma manufacturers.